Aqua Bio Technology — Capital/Financing Update 2024

Jul 4, 2024

AQUA BIO TECHNOLOGY ASA - SHARE CAPITAL INCREASE REGISTERED

AQUA BIO TECHNOLOGY ASA - SHARE CAPITAL INCREASE REGISTERED

4.7.2024 10:08:04 CEST | Aqua Bio Technology ASA | Total number of voting rights

and capital

Reference is made to the stock exchange announcement from Aqua Bio Technology

ASA ("ABT" or the "Company") on 28 June 2024, regarding the Company's board of

directors' resolution to issue a total of 5,908,935 new shares (the "New Shares

") in connection with the settlement of the purchase price for ABT's acquisition

of Ovalen AS and the buy-out of Varming Holding AS related to the Company's

acquisition of Cosmed Beauty AS and Ultrabody AB.

The New Shares will be delivered on a separate ISIN pending publication of an

EEA listing prospectus approved by the Norwegian Financial Supervisory

Authority. The share capital increase pertaining to the issuance of the New

Shares has today been registered with the Norwegian Registry of Business

Enterprises (Nw. Foretaksregisteret). ABT's new share capital is NOK

161,223,182.50 divided into 64,489,273 shares, each with a nominal value of NOK

2,50.

For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941

32 288.

*

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skincare products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skincare products developed by partners towards consumers and

professional users. ABT's focus on commercialization and development of natural

ingredients and natural skincare products has been, and will continue to be, an

important part of the Company's strategy going forward. Aqua Bio Technology is

listed on the Euronext Expand market of the Oslo Stock Exchange.

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/18173561/4740/Download%20announce

ment%20as%20PDF.pdf